We’re proud to be collaborating with Foundation Medicine to present one of fourteen abstracts demonstrating the power of genomic profiling to advance cancer care at the 2022 ESMO – European Society for Medical Oncology, set to be held virtually and in Paris from September 9-13.

We will be presenting “a pan-sarcoma investigation of genetic alterations associated with high telomeric content”. Opportunities such as this allow Omico to strengthen our partnerships and further position ourselves as leaders within the global genomic and precision oncology community.

For further details on the abstract, visit the site here